SIRPant-M

· SIRPant Immunotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIRPant-M, covering 2024-12-20 to 2024-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]